Cargando…

Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities

Objective. The aim of this study was to identify routinely available clinical surrogate markers for potential clotting factor alterations following multiple trauma. Methods. In 68 patients admitted directly from the scene of the accident, all soluble clotting factors were analyzed and clinical data...

Descripción completa

Detalles Bibliográficos
Autores principales: Burggraf, Manuel, Payas, Arzu, Schoeneberg, Carsten, Wegner, Alexander, Kauther, Max Daniel, Lendemans, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940535/
https://www.ncbi.nlm.nih.gov/pubmed/27433474
http://dx.doi.org/10.1155/2016/5614086
_version_ 1782442161174740992
author Burggraf, Manuel
Payas, Arzu
Schoeneberg, Carsten
Wegner, Alexander
Kauther, Max Daniel
Lendemans, Sven
author_facet Burggraf, Manuel
Payas, Arzu
Schoeneberg, Carsten
Wegner, Alexander
Kauther, Max Daniel
Lendemans, Sven
author_sort Burggraf, Manuel
collection PubMed
description Objective. The aim of this study was to identify routinely available clinical surrogate markers for potential clotting factor alterations following multiple trauma. Methods. In 68 patients admitted directly from the scene of the accident, all soluble clotting factors were analyzed and clinical data was collected prospectively. Ten healthy subjects served as control group. Results. Patients showed reduced activities of clotting factors II, V, VII, and X and calcium levels (all P < 0.0001 to 0.01). Levels of hemoglobin and base deficit correlated moderately to highly with the activities of a number of clotting factors. Nonsurvivors and patients who needed preclinical intubation or hemostatic therapy showed significantly reduced factor activities at admission. In contrast, factor VIII activity was markedly elevated after injury in general (P < 0.0001), but reduced in nonsurvivors (P < 0.05). Conclusions. Multiple trauma causes an early reduction of the activities of nearly all soluble clotting factors in general. Initial hemoglobin and, with certain qualifications, base deficit levels demonstrated a potential value in detecting those underlying clotting factor deficiencies. Nevertheless, their role as triggers of a hemostatic therapy as well as the observed response of factor VIII to multiple trauma and also its potential prognostic value needs further evaluation.
format Online
Article
Text
id pubmed-4940535
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-49405352016-07-18 Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities Burggraf, Manuel Payas, Arzu Schoeneberg, Carsten Wegner, Alexander Kauther, Max Daniel Lendemans, Sven Biomed Res Int Research Article Objective. The aim of this study was to identify routinely available clinical surrogate markers for potential clotting factor alterations following multiple trauma. Methods. In 68 patients admitted directly from the scene of the accident, all soluble clotting factors were analyzed and clinical data was collected prospectively. Ten healthy subjects served as control group. Results. Patients showed reduced activities of clotting factors II, V, VII, and X and calcium levels (all P < 0.0001 to 0.01). Levels of hemoglobin and base deficit correlated moderately to highly with the activities of a number of clotting factors. Nonsurvivors and patients who needed preclinical intubation or hemostatic therapy showed significantly reduced factor activities at admission. In contrast, factor VIII activity was markedly elevated after injury in general (P < 0.0001), but reduced in nonsurvivors (P < 0.05). Conclusions. Multiple trauma causes an early reduction of the activities of nearly all soluble clotting factors in general. Initial hemoglobin and, with certain qualifications, base deficit levels demonstrated a potential value in detecting those underlying clotting factor deficiencies. Nevertheless, their role as triggers of a hemostatic therapy as well as the observed response of factor VIII to multiple trauma and also its potential prognostic value needs further evaluation. Hindawi Publishing Corporation 2016 2016-06-28 /pmc/articles/PMC4940535/ /pubmed/27433474 http://dx.doi.org/10.1155/2016/5614086 Text en Copyright © 2016 Manuel Burggraf et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Burggraf, Manuel
Payas, Arzu
Schoeneberg, Carsten
Wegner, Alexander
Kauther, Max Daniel
Lendemans, Sven
Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities
title Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities
title_full Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities
title_fullStr Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities
title_full_unstemmed Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities
title_short Evaluation of Potential Clinical Surrogate Markers of a Trauma Induced Alteration of Clotting Factor Activities
title_sort evaluation of potential clinical surrogate markers of a trauma induced alteration of clotting factor activities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940535/
https://www.ncbi.nlm.nih.gov/pubmed/27433474
http://dx.doi.org/10.1155/2016/5614086
work_keys_str_mv AT burggrafmanuel evaluationofpotentialclinicalsurrogatemarkersofatraumainducedalterationofclottingfactoractivities
AT payasarzu evaluationofpotentialclinicalsurrogatemarkersofatraumainducedalterationofclottingfactoractivities
AT schoenebergcarsten evaluationofpotentialclinicalsurrogatemarkersofatraumainducedalterationofclottingfactoractivities
AT wegneralexander evaluationofpotentialclinicalsurrogatemarkersofatraumainducedalterationofclottingfactoractivities
AT kauthermaxdaniel evaluationofpotentialclinicalsurrogatemarkersofatraumainducedalterationofclottingfactoractivities
AT lendemanssven evaluationofpotentialclinicalsurrogatemarkersofatraumainducedalterationofclottingfactoractivities